Genotype-phenotype relationships in a mouse model for human small-cell lung cancer

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 70, Issue , 2005, Pages 225-232

  Calbo J ^a   Meuwissen, R ^a   Van Montfort, E ^a   Van Tellingen, O ^a   Berns, A ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; MYC PROTEIN; PROTEIN P16INK4A; PROTEIN P53; PROTEIN RETINOBLASTOMA 1; RAS PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 2A; EPIDERMAL GROWTH FACTOR RECEPTOR; RETINOBLASTOMA PROTEIN; SYNAPTOPHYSIN;

CANCER CELL CULTURE; CANCER INVASION; CANCER STAGING; CHROMOSOME 3P; CHROMOSOME ABERRATION; CONFERENCE PAPER; CORRELATION ANALYSIS; GENE AMPLIFICATION; GENOTYPE; HISTOPATHOLOGY; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; METASTASIS; MOLECULAR PHYLOGENY; NEUROENDOCRINE SYSTEM; NONHUMAN; ONCOGENE C MYB; PHENOTYPE; PRIORITY JOURNAL; TUMOR MODEL; TUMOR SUPPRESSOR GENE; ADENOCARCINOMA; ARTICLE; CANCER GROWTH; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG RESISTANCE; GENE EXPRESSION; GENE FREQUENCY; GENOTYPE PHENOTYPE CORRELATION; HISTOLOGY; IMMUNODETECTION; LARGE CELL CARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; NEUROSECRETORY CELL; ONCOGENE RAS; SMALL CELL LUNG CANCER; SQUAMOUS CELL CARCINOMA;

ANIMALS; CARCINOMA, SMALL CELL; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; GENES, P53; GENOTYPE; HUMANS; LUNG NEOPLASMS; MICE; MICE, MUTANT STRAINS; MICE, TRANSGENIC; PHENOTYPE; RETINOBLASTOMA PROTEIN;

EID: 33746428548     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2005.70.026     Document Type: Conference Paper

References (41)

1. Ball D.W., Azzoli C.G., Baylin S.B., Chi D., Dou S., Donis-Keller H., Cumaraswamy A., Borges M., and Nelkin B.D. 1993. Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors. Proc. Natl. Acad. Sci. 90: 5648.
2. Bernards R. and Weinberg R.A. 2002. A progression puzzle. Nature 418: 823.
3. Borges M., Linnoila R.I., van de Velde H.J., Chen H., Nelkin B.D., Mabry M., Baylin S.B., and Ball D.W. 1997. An achaete-scute homologue essential for neuroendocrine differentiation in the lung. Nature 386: 852.
4. Brambilla E., Negoescu A., Gazzeri S., Lantuejoul S., Moro D., Brambilla C., and Coll J.L. 1996. Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors. Am. J. Pathol. 149: 1941.
5. Brambilla E., Moro D., Gazzeri S., Brichon P.Y., Nagy-Mignotte H., Morel F., Jacrot M., and Brambilla C. 1991. Cytotoxic chemotherapy induces cell differentiation in small-cell lung carcinoma. J. Clin. Oncol. 9: 50.
6. Dean M., Fojo T., and Bates S. 2005. Tumour stem cells and drug resistance. Nat. Rev. Cancer 5: 275.
7. Dosaka-Akita H., Hu S.X., Fujino M., Harada M., Kinoshita I., Xu H.J., Kuzumaki N., Kawakami Y., and Benedict W.F. 1997. Altered retinoblastoma protein expression in nonsmall cell lung cancer: Its synergistic effects with altered ras and p53 protein status on prognosis. Cancer 79: 1329.
8. Fathi Z., Way J.W., Corjay M.H., Viallet J., Sausville E.A., and Battey J.F. 1996. Bombesin receptor structure and expression in human lung carcinoma cell lines. J. Cell. Biochem. Suppl. 24: 237.
9. Fong K.M., Sekido Y., Gazdar A.F., and Minna J.D. 2003. Lung cancer. 9: Molecular biology of lung cancer: Clinical implications. Thorax 58: 892.
10. Forgacs E., Zochbauer-Muller S., Olah E., and Minna J.D. 2001. Molecular genetic abnormalities in the pathogenesis of human lung cancer. Pathol. Oncol. Res. 7: 6.
11. Giangreco A., Reynolds S.D., and Stripp B.R. 2002. Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction. Am. J. Pathol. 161: 173.
12. Guerra C., Mijimolle N., Dhawahir A., Dubus P., Barradas M., Serrano M., Campuzano V., and Barbacid M. 2003. Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. Cancer Cell 4: 111.
13. Harris H. 2004. Tumour suppression: Putting on the brakes. Nature 427: 201.
14. Hong K.U., Reynolds S.D., Giangreco A., Hurley C.M., and Stripp B.R. 2001. Clara cell secretory protein-expressing cells of the airway neuroepithelial body microenvironment include a label-retaining subset and are critical for epithelial renewal after progenitor cell depletion. Am. J. Respir. Cell Mol. Biol. 24: 671.
15. Hong K.U., Reynolds S.D., Watkins S., Fuchs E., and Stripp B.R. 2004. Basal cells are a multipotent progenitor capable of renewing the bronchial epithelium. Am. J. Pathol. 164: 577.
16. Hynes R.O. 2003. Metastatic potential: Generic predisposition of the primary tumor or rare, metastatic variants-or both? Cell 113: 821.
17. Jackson E.L., Willis N., Mercer K., Bronson R.T., Crowley D., Montoya R., Jacks T., and Tuveson D.A. 2001. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 15: 3243.
18. Johnson L., Mercer K., Greenbaum D., Bronson R.T., Crowley D., Tuveson D.A., and Jacks T. 2001. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 410: 1111.
19. Jonkers J. and Berns A. 2002. Conditional mouse models of sporadic cancer. Nat. Rev. Cancer 2: 251.
20. Kang Y., Siegel P.M., Shu W., Drobnjak M., Kakonen S.M., Cordon-Cardo C., Guise T.A., and Massague J. 2003. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3: 537.
21. Kim C.F., Jackson E.L., Woolfenden A.E., Lawrence S., Babar I., Vogel S., Crowley D., Bronson R.T., and Jacks T. 2005. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121: 823.
22. Kraus A.C., Ferber I., Bachmann S.O., Specht H., Wimmel A., Gross M.W., Schlegel J., Suske G., and Schuermann M. 2002. In vitro chemo- and radio-resistance in small cell lung cancer correlates with cell adhesion and constitutive activation of AKT and MAP kinase pathways. Oncogene 21: 8683.
23. Landis S.H., Murray T., Bolden S., and Wingo P.A. 1999. Cancer statistics, 1999. CA Cancer J. Clin. 49: 8.
24. Maulik G., Kijima T., and Salgia R. 2003. Role of receptor tyrosine kinases in lung cancer. Methods Mol. Med. 74: 113.
25. Meuwissen R. and Berns A. 2005. Mouse models for human lung cancer. Genes Dev. 19: 643.
26. Meuwissen R., Linn S.C., van der Valk M., Mooi W.J., and Berns A. 2001. Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene. Oncogene 20: 6551.
27. Meuwissen R., Linn S.C., Linnoila R.I., Zevenhoven J., Mooi W.J., and Berns A. 2003. Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell 4: 181.
28. Minn A.J., Kang Y., Serganova I., Gupta G.P., Giri D.D., Doubrovin M., Ponomarev V., Gerald W.L., Blasberg R., and Massague J. 2005. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J. Clin. Invest. 115: 44.
29. Paez J.G., Janne P.A., Lee J.C., Tracy S., Greulich H., Gabriel S., Herman P., Kaye F.J., Lindeman N., Boggon T.J., Naoki K., Sasaki H., Fujii Y., Eck M.J., Sellers W.R., Johnson B.E., and Meyerson M. 2004. EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy. Science 304: 1497.
30. Ramaswamy S., Ross K.N., Lander E.S., and Golub T.R. 2003. A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33: 49.
31. Reissmann P.T., Koga H., Takahashi R., Figlin R.A., Holmes E.C., Piantadosi S., Cordon-Cardo C., and Slamon D.J. 1993. Inactivation of the retinoblastoma susceptibility gene in nonsmall-cell lung cancer. The Lung Cancer Study Group. Oncogene 8: 1913.
32. Richardson G.E. and Johnson B.E. 1993. The biology of lung cancer. Semin. Oncol. 20: 105.
33. Rozengurt E. 1998. V. Gastrointestinal peptide signaling through tyrosine phosphorylation of focal adhesion proteins. Am. J. Physiol. 275: G177.
34. Schmidt-Kittler O., Ragg T., Daskalakis A., Granzow M., Ahr A., Blankenstein T.J., Kaufmann M., Diebold J., Arnholdt H., Muller P., Bischoff J., Harich D., Schlimok G., Riethmuller G., Eils R., and Klein C.A. 2003. From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression. Proc. Natl. Acad. Sci. 100: 7737.
35. Toyooka S., Tsuda T., and Gazdar A.F. 2003. The TP53 gene, tobacco exposure, and lung cancer. Hum. Mutat. 21: 229.
36. van de Vijver M.J., He Y.D., van't Veer L.J., Dai H., Hart A.A., Voskuil D.W., Schreiber G.J., Peterse J.L., Roberts C., Marton M.J., Parrish M., Atsma D., Witteveen A., Glas A., Delahaye L., van der Velde T., Bartelink H., Rodenhuis S., Rutgers E.T., Friend S.H., and Bernards R. 2002. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347: 1999.
37. van 't Veer L.J., Dai H., van de Vijver M.J., He Y.D., Hart A.A., Mao M., Peterse H.L., van der Kooy K., Marton M.J., Witteveen A.T., Schreiber G.J., Kerkhoven R.M., Roberts C., Linsley P.S., Bernards R., and Friend S.H. 2002. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530.
38. Watkins D.N., Berman D.M., Burkholder S.G., Wang B., Beachy P.A., and Baylin S.B. 2003. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 422: 313.
39. Wikenheiser-Brokamp K.A. 2004. Rb family proteins differentially regulate distinct cell lineages during epithelial development. Development 131: 4299.
40. Worden F.P. and Kalemkerian G.P. 2000. Therapeutic advances in small cell lung cancer. Expert Opin. Investig. Drugs 9: 565.
41. Zochbauer-Muller S., Gazdar A.F., and Minna J.D. 2002. Molecular pathogenesis of lung cancer. Annu. Rev. Physiol. 64: 681.